Effets hémodynamiques de l’administration de vasopressine au décours de l’Arrêt Cardio-Respiratoire chez des patients en état de choc réfractaireHemodynamic effects of vasopressin administration in patient with refractory shock following successfully resuscitated cardiac arrest
Active, not recruiting
- Conditions
- Patients admitted in ICU after sucessfully resuscitated cardiac arrest and developping a refractory shockMedDRA version: 8.1Level: LLTClassification code 10047146Term: Vasopressin
- Registration Number
- EUCTR2006-005421-31-FR
- Lead Sponsor
- RER Saint Denis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Patient admitted after successfully resuscitated cardiac arrest requiring high level of vasopressor support
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Age <18
Cardiac index < 2.5 l/min/square meter
or Svo2 < 70%
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: A decrease of the need of vasopressor support.;Secondary Objective: Evolution of venous oxygen saturation and organ dysfunction score (LOD, SOFA);Primary end point(s): Decrease in the need of vasopressor support
- Secondary Outcome Measures
Name Time Method